A judge has refused an application by generic drug maker Juno Pharmacueticals to withdraw an admission in a battle with Millennium Pharmaceuticals over its cheap version of breakthrough cancer drug Velcade, denying Juno a potential defence to allegations of patent infringement.
A shareholder class action against Woolworths related to its downward revision of a 2015 profit guidance is seeking emails and other documents from a slew of current and former company executives, including the grocery chain’s former Chairman and CEO, who departed in the wake of disappointing financial results.
The sought-after commission at the centre of an unsuccessful common fund application in a class action over the use of toxic foam at a RAAF base near Katherine, NT has been revealed as 15% of any gross recovery in the case plus up to three and a half times the funder’s costs.
The litigation funder backing a consumer protection class action against mortgage lending and investment firm RMBL Investments will earn a step-up commission of 30% if the case continues into September, according to a proposed common fund order.
After putting to rest a trademark dispute with the Taronga Zoo, the still unopened Sydney Zoo is facing another legal challenge from a competing zoo alleging it is threatening to violate the terms of its development consent.
Accounting firm Pitcher Partners, which is facing two shareholder class actions over auditing work for Slater & Gordon, is considering filing claims of its own against the law firm’s current auditor, Ernst & Young.
An appeals court has revived a class action against a NSW council over loss and damage resulting from a 2009 tip rubbish fire, and awarded the lead applicant over $100,000 in damages.
Construction giant Lendlease has been hit with a class action over allegedly inadequate disclosures relating to its engineering and services business, which includes the NorthConnex tunnel road project in Sydney.
Ticket reseller Viagogo will face penalties after the court found it duped customers into thinking it was an official ticket vendor and failed to disclose booking fees of around 28 per cent, causing some customers to pay hundreds of dollars more than what their tickets were actually worth.
Horse vaccine maker Zoetis has appealed a ruling that denied its request for $450,000 as security for costs in an unfunded class action accusing it of failing to warn about the vaccine’s side effects.